Literature DB >> 17989072

Purified NPC1 protein: II. Localization of sterol binding to a 240-amino acid soluble luminal loop.

Rodney E Infante1, Arun Radhakrishnan, Lina Abi-Mosleh, Lisa N Kinch, Michael L Wang, Nick V Grishin, Joseph L Goldstein, Michael S Brown.   

Abstract

Defects in Niemann-Pick, Type C-1 protein (NPC1) cause cholesterol, sphingolipids, phospholipids, and glycolipids to accumulate in lysosomes of liver, spleen, and brain. In cultured fibroblasts, NPC1 deficiency causes lysosomal retention of lipoprotein-derived cholesterol after uptake by receptor-mediated endocytosis. NPC1 contains 1278 amino acids that form 13 membrane-spanning helices and three large loops that project into the lumen of lysosomes. We showed earlier that NPC1 binds cholesterol and oxysterols. Here we localize the binding site to luminal loop-1, a 240-amino acid domain with 18 cysteines. When produced in cultured cells, luminal loop-1 was secreted as a soluble dimer. This loop bound [(3)H]cholesterol (K(d), 130 nM) and [(3)H]25-hydroxycholesterol (25-HC, K(d), 10 nM) with one sterol binding site per dimer. Binding of both sterols was competed by oxysterols (24-, 25-, and 27-HC). Unlabeled cholesterol competed strongly for binding of [(3)H]cholesterol, but weakly for [(3)H]25-HC binding. Binding of [(3)H]cholesterol but not [(3)H]25-HC was inhibited by detergents. We also studied NPC2, a soluble protein whose deficiency causes a similar disease phenotype. NPC2 bound cholesterol, but not oxysterols. Epicholesterol and cholesteryl sulfate competed for [(3)H]cholesterol binding to NPC2, but not NPC1. Glutamine 79 in luminal loop-1 of NPC-1 is important for sterol binding; a Q79A mutation abolished binding of [(3)H]cholesterol and [(3)H]25-HC to full-length NPC1. Nevertheless, the Q79A mutant restored cholesterol transport to NPC1-deficient Chinese hamster ovary cells. Thus, the sterol binding site on luminal loop-1 is not essential for NPC1 function in fibroblasts, but it may function in other cells where NPC1 deficiency produces more complicated lipid abnormalities.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17989072     DOI: 10.1074/jbc.M707944200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  101 in total

1.  Characterization of the Niemann-Pick C pathway in alveolar type II cells and lamellar bodies of the lung.

Authors:  Blair R Roszell; Jian-Qin Tao; Kevin J Yu; Shaohui Huang; Sandra R Bates
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-02-24       Impact factor: 5.464

2.  Niemann-Pick type C 1 function requires lumenal domain residues that mediate cholesterol-dependent NPC2 binding.

Authors:  Maika S Deffieu; Suzanne R Pfeffer
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-07       Impact factor: 11.205

3.  Npc1 haploinsufficiency promotes weight gain and metabolic features associated with insulin resistance.

Authors:  David Jelinek; Veronica Millward; Amandip Birdi; Theodore P Trouard; Randall A Heidenreich; William S Garver
Journal:  Hum Mol Genet       Date:  2010-10-29       Impact factor: 6.150

4.  Therapeutic potential of cyclodextrins in the treatment of Niemann-Pick type C disease.

Authors:  Benny Liu
Journal:  Clin Lipidol       Date:  2012-06

5.  Extracellular loop C of NPC1L1 is important for binding to ezetimibe.

Authors:  Adam B Weinglass; Martin Kohler; Uwe Schulte; Jessica Liu; Emmanuel O Nketiah; Anu Thomas; William Schmalhofer; Brande Williams; Wolfgang Bildl; Daniel R McMasters; Kevin Dai; Lindsey Beers; Margaret E McCann; Gregory J Kaczorowski; Maria L Garcia
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-05       Impact factor: 11.205

6.  Scientific side trips: six excursions from the beaten path.

Authors:  Michael S Brown; Joseph L Goldstein
Journal:  J Biol Chem       Date:  2012-05-14       Impact factor: 5.157

Review 7.  Niemann-Pick C2 (NPC2) and intracellular cholesterol trafficking.

Authors:  Judith Storch; Zhi Xu
Journal:  Biochim Biophys Acta       Date:  2009-02-13

8.  New variants in Spanish Niemann-Pick type c disease patients.

Authors:  Laura López de Frutos; Jorge J Cebolla; Luis Aldámiz-Echevarría; Ángela de la Vega; Sinziana Stanescu; Carlos Lahoz; Pilar Irún; Pilar Giraldo
Journal:  Mol Biol Rep       Date:  2020-02-14       Impact factor: 2.316

Review 9.  The LDL receptor.

Authors:  Joseph L Goldstein; Michael S Brown
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-04       Impact factor: 8.311

10.  Cyclodextrin triggers MCOLN1-dependent endo-lysosome secretion in Niemann-Pick type C cells.

Authors:  Fabrizio Vacca; Stefania Vossio; Vincent Mercier; Dimitri Moreau; Shem Johnson; Cameron C Scott; Jonathan Paz Montoya; Marc Moniatte; Jean Gruenberg
Journal:  J Lipid Res       Date:  2019-02-01       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.